Arrowstreet Capital’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$167K Buy
+11,953
New +$161K ﹤0.01% 1784
2025
Q3
Sell
-28,703
Closed -$351K 1857
2025
Q2
$351K Sell
28,703
-22,505
-44% -$283K ﹤0.01% 1811
2025
Q1
$734K Sell
51,208
-208,209
-80% -$3.25M ﹤0.01% 1543
2024
Q4
$4.13M Sell
259,417
-195,514
-43% -$3.87M ﹤0.01% 1060
2024
Q3
$10.9M Buy
454,931
+357,750
+368% +$8.18M 0.01% 723
2024
Q2
$1.94M Sell
97,181
-134,179
-58% -$2.61M ﹤0.01% 1082
2024
Q1
$4.61M Buy
231,360
+5,720
+3% +$111K ﹤0.01% 916
2023
Q4
$5.06M Buy
+225,640
New +$4.66M 0.01% 746
2023
Q3
Sell
-169,440
Closed -$4.33M 1250
2023
Q2
$4.33M Sell
169,440
-343,405
-67% -$9.04M 0.01% 654
2023
Q1
$15.3M Buy
512,845
+178,426
+53% +$5.18M 0.02% 461
2022
Q4
$9.05M Buy
334,419
+156,702
+88% +$3.83M 0.01% 548
2022
Q3
$3.87M Buy
177,717
+97,346
+121% +$2.54M 0.01% 715
2022
Q2
$2.2M Sell
80,371
-68,871
-46% -$1.98M ﹤0.01% 756
2022
Q1
$5M Buy
+149,242
New +$4.81M 0.01% 634
2021
Q3
Sell
-225,813
Closed -$8.21M 1581
2021
Q2
$8.21M Sell
225,813
-51,460
-19% -$2.13M 0.01% 902
2021
Q1
$12.1M Buy
277,273
+95,525
+53% +$4.48M 0.02% 790
2020
Q4
$8.34M Buy
+181,748
New +$7.56M 0.01% 956
2020
Q3
Sell
-96,317
Closed -$2.83M 2321
2020
Q2
$2.83M Buy
96,317
+81,617
+555% +$2.36M 0.01% 1312
2020
Q1
$396K Buy
+14,700
New +$439K ﹤0.01% 1572
2016
Q4
Sell
-304,345
Closed -$10.5M 1651
2016
Q3
$10.5M Buy
+304,345
New +$10.7M 0.03% 433
2016
Q1
Sell
-281,965
Closed -$9.42M 1331
2015
Q4
$9.42M Sell
281,965
-86,790
-24% -$2.7M 0.04% 363
2015
Q3
$10.5M Buy
368,755
+71,176
+24% +$2.48M 0.05% 336
2015
Q2
$12.1M Sell
297,579
-140,765
-32% -$6.32M 0.07% 234
2015
Q1
$21.6M Sell
438,344
-162,929
-27% -$7.55M 0.13% 176
2014
Q4
$27.3M Buy
+601,273
New +$23.6M 0.16% 145

Other funds holding AVNS